EUVIMED · CrossrefJournal
Inside Precision Medicine
ISSN 2770-2294 · SAGE Publications
Latest articles
Stopping Neurodegeneration in Place with Vaccines
Two Women, One Mission: Closing the Gap Between Cancer Science and Survival
Rewriting Cancer Care Through Epigenetics
ASKED & ANSWERED Pioneering innovation in transplant diagnostics
From Multi-Omics to Digital Twins: A Data-Driven Future for Precision Medicine
5 BEYOND THE GENOME: FIVE EMERGING LEADERS IN EPIGENETICS DIAGNOSTICS
Paper Mills and The Fight Against Scientific Fraud
IN CONVERSATION with Olga Colgan & Darren Treanor
Organs-on-a-Chip Offer “Elegant Solution” to Quandary of Animal Models in Drug Design
Entreprecisioneur Cyclana Bio Is Exploring the Extracellular Matrix to Treat Endometriosis A Discussion with Léa Wenger, PhD
Chasing the Zero That Matters
Moving In Vivo : Next Steps For CAR T-Cell Therapy
THE DIGITAL PATH TO AI IN CANCER CARE
From Reactive to Proactive: Reimagining Hypertension Management in the Precision Medicine Era
In CONVERSATION with Haijiao Liu, PhD
Biobanks Set the Stage for Scaling Precision Medicine
Rewriting Life Before Birth: Entering the Fetal Genetic Intervention Era
Entreprecisioneur Igyxos Biotherapeutics is Enhancing Hormone Activity to Treat Infertility A Discussion with Marie-Christine Maurel, PhD
FcRn Inhibition in Autoimmune Disease: 2026 Outlook for Graves’ Disease, Alloimmune Conditions, and Sjögren’s Disease
5 TOP 5 FIRMS ENGINEERING HEALTHCARE IN THE CNS SPACE
Editor’s Note
Riding the Gene Therapy Rollercoaster Into 2026
When Antibodies Become the Drug Factory
COMPREHENSIVE DEVELOPMENTS Comprehensive genomic profiling plays an increasingly central role in personalized cancer treatment
ASKED & ANSWERED
Manchester Calling: The Families and Scientists Refusing to Let Hunter Syndrome Go Unfunded
The Coming of Age of Spatial Multiomics
Becoming the Master of Your AI Learning Journey
THE TOP 5 CUTTING-EDGE COMPANIES IN CRISPR DIAGNOSTICS
entrePRECISIONeur Revalia Bio’s Quest to Replace Animal Models with Human Organs A Discussion with Greg Tietjen, PhD
EUVIMED